Euan Murray (Senior Scientist) will attend Antibody Engineering & Therapeutics in Basel, June 10-12th 2025, and present a talk titled First-in-class Site-directed Targeted soloMER Drug Conjugate for Autoimmune Inflammation. He will describe the synthesis and characterisation of our bi-functional soloMER Drug Conjugate (SDC) with neutrophil elastase cleavable linker for inflammation site-specific release of payload. His presentation will be in the Antibodies for Autoimmune disease session on Thursday the 12th at 9.30. Come and hear what we have achieved working towards tackling complex autoimmune diseases with rationally designed new therapies.
